|
Market Cap (3-Jul) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
CPH released this announcement to the ASX on 28 February 2022, 16:34. The announcement is not marked as price sensitive, and is 30 page(s) in length and 443.37kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.823% short sold according to ASIC data. It was ranked the 214th most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Appendix 4G and Corporate Governance Statement | 28 February 2022, 16:34 |
| Appendix 4E and Annual Report to Shareholders | 28 February 2022, 16:20 |
| Halucenex secures Clinical Trial Authorisation | 28 February 2022, 9:57 |
| Reinstatement to Official Quotation | 25 February 2022, 9:51 |
You must be logged in to post a reply.
Creso Pharma 